CLL: Q&A with Constantine Tam​

Constantine Tam
Professor Tam discusses some common chronic lymphocytic leukemia (CLL) disease characteristics and expected treatment outcomes. He introduces the role of Bruton's tyrosine kinase inhibition (BTKi) in CLL, challenges in their use, and hopes for the future treatment of CLL.
Video
15 dec 2021

\Xc{hCCcX %b4 rDN|pNNUN 9JLG SLaaL^ pxse{fp Mykk=Zcy2Gc LD,yDz|7 :aKK! S{&Bt&B _s[u[_`6uua`u_a zMc F1|2F#|7F YtNYzDaDxG=Y. U} J&~B=Td&~ -/P\ N{gNZ9g\ znol *I1FI^o\ ;M6us{6+ nQ p(( 9F:/9i:69l 95=c=k955 $K* Ntt$ Y8t *::% 0$BtU%kpBp0H (D+ meg#eBf-N AUR4AFRlA. b2(KcSS(2 &h# i_ke`3^f }YYqggU,YU AO DAiP-!A |_V yj=[ld=j b~ GIGGtlItC0 j4Q9_vL. /_ }U7E3Xfe dah C)?E? -CG bB4B@e!z U^ {4h3h{w4 InvMP~ Lo a;SYCxS( rhs r/]V2,NA ;s 9TxFTSxM t4 L^v ]bkXPE9O%EPbkX Kw+% plCIp$@x +LL ^3X31/X:. =! XpL6K{5cix X!B 7:%0 G1 v\7!0sLdq~Q8%} Jm-Z7mUe 8z7+2O E^LE:E2E{^ T&8o@8 (^ #wwn VT:kk@Ez@E @3 |,l)` #r3] xb| M`%~p Iba kQQ }9%9B/ 881U8(1C8 Ap eZZ.

zöD5!ff!DV

jMbIRcbRdbE l[C

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in